Drug intelligence / Profile preview

co-amoxiclav or dicloxacillin

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Co-amoxiclav is a combination antibiotic containing amoxicillin, a broad-spectrum penicillin-type beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor. The addition of clavulanic acid extends the spectrum of amoxicillin to include bacteria that produce beta-lactamase enzymes, making it effective against many resistant strains. It is used for various infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, sinusitis, otitis media, and dental infections[3][5]. Dicloxacillin is a narrow-spectrum penicillin-class antibiotic designed to resist degradation by beta-lactamases produced by certain Gram-positive bacteria such as Staphylococcus aureus. It is primarily used for mild-to-moderate staphylococcal skin and soft tissue infections (including impetigo), osteomyelitis, septic arthritis, pneumonia (as adjunct), throat infections caused by susceptible organisms, endocarditis prophylaxis in some cases, and surgical prophylaxis[6]. Both drugs act by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins.

Brand names
AugmentinAmoclanAugmentin XRDiclocilDycillDynapenPathocil
Other names
amoxicillin/clavulanate potassiumamoxicillin-clavulanic acidamoxicillin and clavulanate potassiumdicloxacillin sodium
02

Targets

PBP (Penicillin-binding protein family)Class A BL (Class A beta-lactamase)

Beyond the preview

Go deeper on co-amoxiclav or dicloxacillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on co-amoxiclav or dicloxacillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call